| Business Name: |
Amaze Therapeutics |
| Contact Person: |
Paul Laikind |
| Address: |
3010 Science Park Road, San Diego, California 92121 |
| Phone Number: |
(858) 353-0223 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2010 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B & B2C |
| Business Category: |
|
| SIC Code: |
2834 |
| NAICS Code: |
325412 |
| Share This Business: |
|
| Related Businesses: |
Tioga Pharmaceuticals Inc - San Diego, CA 92121
Amplyx Pharmaceuticals Inc - San Diego, CA 92121
Depotech Corp - San Diego, CA 92121
Pacira Pharmaceuticals Inc - San Diego, CA 92121
Amylin Ohio LLC - San Diego, CA 92121
Conatus Pharmaceuticals Inc - San Diego, CA 92121
Novomedix - San Diego, CA 92121
Coda Therapeutics Inc - San Diego, CA 92121
Bioserv Corp - San Diego, CA 92121
Proprius Inc - San Diego, CA 92121
Arena Pharmaceuticals Inc - San Diego, CA 92121
Epigen Biosciences Inc - San Diego, CA 92121
Mirati Therapeutics - San Diego, CA 92121
Formex LLC - San Diego, CA 92121
Prometheus Rxdx Inc - San Diego, CA 92121
Neuropore Therapies - San Diego, CA 92121
Regulus Therapeutics Inc - San Diego, CA 92121
Skyepharma Inc - San Diego, CA 92121
Phage Biotechnology Corporation - San Diego, CA 92121
Advanced Molecular Design Inc - San Diego, CA 92121
|
The company Amaze Therapeutics provides BOTH services in the form of from its single location in California.
1 to 4 employees work for Amaze Therapeutics, and the business now earns $100.000 to $499.999 per annum.
Amaze Therapeutics was launched in 2010 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 .
To contact Amaze Therapeutics, please call Paul Laikind with the phone number (858) 353-0223 or visit its single location at 3010 Science Park Road in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.901837,-117.242456.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.